Who Suffers From Lilly's Evacetrapib Failure?

Lilly hits a late-stage snag that causes worries about its pipeline potential and has repercussions for several other companies working in the cholesterol space.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America